Composition and method for treating macular degeneration

Details for Australian Patent Application No. 2004286823 (hide)

Owner Celgene Corporation

Inventors Zeldis, Jerome B.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2004286823

PCT Pub. Number WO2005/044259

Priority 10/699,154 30.10.03 US

Filing date 28 April 2004

Wipo publication date 19 May 2005

International Classifications

A61K 31/454 (2006.01)

A61K 31/43 (2006.01)

A61K 31/522 (2006.01)

A61K 31/545 (2006.01) - Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula , e.g. cephalosporins, cefaclor, cephalexine

A61K 31/557 (2006.01) - Eicosanoids, e.g. leukotrienes

A61K 31/56 (2006.01) - Compounds containing cyclopenta[a]hydrophenanthrene ring systems

A61K 38/18 (2006.01) Medicinal preparations containing peptides - Growth factors

A61K 38/21 (2006.01) Medicinal preparations containing peptides - Interferons

A61K 38/27 (2006.01) Medicinal preparations containing peptides - Growth hormone (GH) (Somatotropin)

Event Publications

8 June 2006 PCT application entered the National Phase

  PCT publication WO2005/044259 Priority application(s): WO2005/044259

25 November 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004286824-Cytokine inhibitory drugs for treatment of macular degeneration

2004286819-Methods of using and compositions comprising selective cytokine inhibitory drugs for treatment, modification and management of pain